儿科队列中钆基对比剂急性反应:16237次注射的回顾性研究
该回顾性研究分析了2009年6月1日至2017年5月9日期间在某机构接受钆基对比剂MRI检查的10190例儿科患者(<18岁),共16237次注射。类过敏反应发生率为0.10%(17/16237),生理性反应为0.14%(23/16237),无严重反应。钆贝葡胺的类过敏反应发生率显著高于钆双胺(0.49% vs 0.04%,p<.001),腹部/盆腔及心脏MRI检查的类过敏反应发生率也显著高于头部检查。
要点
- 儿科患者钆基对比剂急性反应发生率低:类过敏0.10%、生理性0.14%,无严重反应。
- 钆贝葡胺类过敏反应发生率显著高于钆双胺(0.49% vs 0.04%,p<.001)。
- 腹部/盆腔或心脏MRI检查的类过敏反应发生率显著高于头部检查。
诊断标准与关键数值
- 类过敏反应发生率为0.10%(17/16237),生理性反应发生率为0.14%(23/16237),无严重反应。
- 钆贝葡胺的类过敏反应发生率为0.49%,显著高于钆双胺的0.04%(p<.001)。
- 腹部或盆腔MRI检查的类过敏反应发生率为0.38%,显著高于头部检查的0.05%(p<.001);心脏检查的类过敏反应发生率为0.55%,显著高于头部检查的0.05%(p=.006)。
- 12-17岁患者的生理性反应发生率为0.25%,显著高于2至<12岁患者的0.03%(p<.001);腹部或盆腔检查的生理性反应发生率为0.38%,显著高于头部检查的0.10%(p=.002)。
- 在有既往钆基对比剂类过敏反应的患者中进行的16次MRI检查,仅1次出现重复反应。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND. Incidences and risk factors for acute reactions to gadolinium-based contrast agents (GBCAs) are not fully understood, particularly in pediatric patients. OBJECTIVE. The purpose of this study was to retrospectively examine allergiclike and physiologic acute reactions in pediatric patients who receive GBCAs for MRI examinations. METHODS. The study cohort consisted of all pediatric patients (age < 18 years old) who underwent an MRI examination with a GBCA at our institution from June 1, 2009, to May 9, 2017. Acute reactions were identified by medical record review and classified by severity using the American College of Radiology guidelines. Potential risk factors for reactions were examined using generalized estimating equation methods accounting for rare events. RESULTS. A total of 16,237 GBCA injections (10,141 gadodiamide injections, 4880 gadobutrol injections, and 1216 gadobenate dimeglumine injections) were administered to a study cohort of 10,190 patients (49% [7982/16,237] girls and 51% [8255/16,237] boys). Incidences of 0.10% (17/16,237) for allergiclike and 0.14% (23/16,237) for physiologic reactions were observed. No severe reactions occurred. Allergiclike reaction incidences were significantly higher with gadobenate compared with gadodiamide (0.49% vs 0.04%; p < .001) and in patients who underwent abdominal or pelvic MRI examinations (0.38%) or cardiac examinations (0.55%) compared with head examinations (0.05%; p < .001 and p = .006, respectively). Physiologic reaction incidences were significantly higher in older patients (0.25% in patients 12-17 years old vs 0.03% in patients 2 to < 12 years old; p < .001) and in patients who underwent abdominal or pelvic examinations compared with head examinations (0.38% vs 0.10%; p = .002). Of 16 MRI examinations performed in patients with a prior allergiclike reaction to GBCAs, only one resulted in a repeat reaction. CONCLUSION. In this pediatric cohort, GBCA type, patient age, and MRI type were risk factors for acute reactions. Repeat reactions were rare. CLINICAL IMPACT. Providers must weigh the risks and benefits when choosing a particular GBCA to use in their practices and must consider multiple, potentially disparate risks associated with each GBCA.
引用
- McDonald JS, Larson NB, Kolbe AB, et al. Acute Reactions to Gadolinium-Based Contrast Agents in a Pediatric Cohort: A Retrospective Study of 16,237 Injections. AJR Am J Roentgenol. 2020. PMID: 32755216. doi:10.2214/AJR.20.23602
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。